Lung - Alzahouri: Cost-effectiveness analysis of strategies introducing FDG-PET into the
mediastinal staging of non-small-cell lung cancer from the French healthcare system
perspective. Clinical Radiology (2005) 60, 479–492
General - The AMCP Format for Formulary Submissions Ver 21. April 2005
The Format and other formulary submission guidelines support the informed selection
of pharmaceuticals, biologics and vaccines by: Standardizing and communicating
product and supporting program information requirements;
General - Arrive´: A Scale of Methodological Quality for Clinical Studies of Radiologic
Examinations. Radiology 2000; 217:69–74
PET - Cleemput: Methodology for calculating a country’s need for positron emission
tomography scanners. Internat J Technol Assess in Health Care, 24:1 (2008), 20–24.
General - Primer on Cost-Effectiveness Analysis
PET - Czernin: Improvements in Cancer Staging with PET/CT: Literature-Based
Evidence as of September 2006. J Nucl Med 2007; 48:78S–88S
PET - Facey: Overview of the clinical effectiveness of positron emission tomography
imaging in selected cancers. Health Technology Assessment 2007; Vol. 11: No. 44
H&N - Fleming: Impact of FDG PET/CT on Previously Untreated Head and Neck
Cancer Patients. Laryngoscope, 117:1173–1179, 2007
General - Fryback: The Efficacy of Diagnostic Imaging. Med Decis Making
1991;11:88- 94
Colorectal - Garden: Guidelines for resection of colorectal cancer liver metastases. Gut
2006;55;1-8
General - Gazelle: Cost-effectiveness Analysis in the Assessment of Diagnostic Imaging
Technologies. Radiology 2005; 235:361–370
PET - Hastings: Joint project of the international network of agencies for health
technology assessment—Part 1: Survey results on diffusion, assessment, and clinical use
of positron emission tomography. Internat J Technol Assess in Health Care, 22:2 (2006),
143–148.
General - Kielar: Health-Related Quality of Life and Cost-Effectiveness Analysis in
Radiology. Acad Radiol 2007; 14:411–419
PET - Krug: Is a methodology available that accurately measures the cost of an FDGPET study? Eur J Nucl Med Mol Imaging (2007) 34:625–627
General - Krupinski: Anniversary Paper: Evaluation of medical imaging systems. Med.
Phys. 35 (2), February 2008 pp645-659
The authors review the hierarchical model of the efficacy of diagnostic imaging
systems by Fryback and Thornbury
Lymphoma - Kwee: Imaging in staging of malignant lymphoma: a systematic review.
Blood. 2008;111:504-516
Colorectal - Lejeune: Use of a Decision Analysis Model to Assess the CostEffectiveness of FDG PET in the Management of Metachronous Liver Metastases of
Colorectal Cancer. J Nucl Med 2005; 46:2020–2028
Cardiac - Merhige: Impact of Myocardial Perfusion Imaging with PET and 82Rb on
Downstream Invasive Procedure Utilization, Costs, and Outcomes in Coronary Disease
Management. J Nucl Med 2007; 48:1069–1076
PET - Muller: Overview of Economic Evaluation of Positron-Emission Tomography.
The European Journal of Health Economics, Vol. 3, No. 1. (2002), pp. 59-65.
General - Murray: Development of WHO guidelines on generalized cost-effectiveness
analysis. Health Econ. 9: 235–251 (2000)
Cardiac - Nandalur: Diagnostic performance of positron emission tomography in the
detection of coronary artery disease: a meta-analysis. Acad Radiol. 2008 Apr;15(4):44451
PET - Podoloff: NCCN Task Force Report: PET/CT Scanning in Cancer. JNCCN 2007;
5(Suppl 1):S1–S22
PET - PET SCAN PRIMER: A Guide to the Implementation of Positron Emission
Tomography Imaging in Ontario August 31, 2008
Colorectal - Park: Decision Analysis for the Cost-Effective Management of Recurrent
Colorectal Cancer. ANNALS OF SURGERY Vol. 233, No. 3, 310–319. 2001
Colorectal - Pelosi. The role of FDG-PET in the management of patients with colorectal
cancer: A Review. Eur J Surg Oncol. 2007 Feb;33(1):1-6.
Colorectal - Sheehan: FDG PET in Preoperative Assessment of Colorectal Liver
Metastases Combining “Evidence-Based Practice” and “Technology Assessment”
Methods to Develop Departmental Imaging Protocols: Should FDG PET Be Routinely
Used in the Preoperative Assessment of Patients With Colorectal Liver Metastases? Acad
Radiol 2007; 14:389–397
General - Singer: Cost-Effectiveness Analysis in Radiology. Radiology 2001; 219:611–
620
Colorectal - SSAT: Society for Surgery of the Alimentary Tract - Patient Care
Guidelines: Surgery for Hepatic Colorectal Metastases. Approved May 15, 2004
General - The STARD checklist for reporting information in diagnostic accuracy studies
General - STARD Flowchart
General - Streiner: Diagnosing Tests: Using and Misusing Diagnostic and Screening
Tests. JOURNAL OF PERSONALITY ASSESSMENT, 81(3), 209–219
Lymphoma - Strobel: Cost-effective therapy remission assessment in lymphoma patients
using FDG PET/CT: is an end of treatment exam necessary in all patients? Annals of
Oncology 18: 658–664, 2007
H&N - van Hooren: The cost-effectiveness of (18)FDG-PET in selecting patients with
suspicion of recurrent laryngeal carcinoma after radiotherapy for direct laryngoscopy.
Eur Arch Otorhinolaryngol. 2008 Nov 29
General - Walker: How to do (or not to do). . . Cost and cost-effectiveness guidelines:
which ones to use? HEALTH POLICY AND PLANNING 2001; 16(1): 113–121
Lung - Yap: Positron emission tomography with selected mediastinoscopy compared to
routine mediastinoscopy offers cost and clinical outcome benefits for pre-operative
staging of non-small cell lung cancer. Eur J Nucl Med Mol Imaging (2005) 32:1033–
1040
H&N - Yen: The Cost-utility Analysis of FDG PET in the Diagnosis of Recurrent
Nasopharyngeal Carcinoma. Acad Radiol. 2009 Jan;16(1):54-60.
Colorectal - Zubeldia: The Economic Impact of 18FDG Positron Emission Tomography
in the Surgical Management of Colorectal Cancer with Hepatic Metastases. Ca
Biotherapy & Radiopharm. Volume 20, Number 4, 2005. pp 450-456.